Array Bridge is Biotechnology in United States that focus on bio-therapeutic drugs business. Founded in 2010. They cover business area such as producer, pharmaceutical and medical product, immunoassay, bio-therapeutic drug, antibody array, biosimilar and antibody-drug conjugate, three-dimensional conformational comparability analysis, engage, drug development, detection, host cell protein, dna contaminant, client, antibody production, bind-base bioassay method qualification, validation.
2010
( 14 years old in 2024 )
Bio-therapeutic Drugs
-
4340 Duncan Avenue
Suite 222
Saint Louis, MO 63110
United States
Private
producerpharmaceutical and medical productimmunoassaybio-therapeutic drugantibody arraybiosimilar and antibody-drug conjugatethree-dimensional conformational comparability analysisengagedrug developmentdetectionhost cell proteindna contaminantclientantibody productionbind-base bioassay method qualificationvalidation
* We use standard office opening hours in near Array Bridge's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Array Bridge is Biotechnology business from United States that founded in 2010 (14 years old in 2024), Array Bridge business is focusing on Bio-therapeutic Drugs.
Array Bridge headquarter office and corporate office address is located in 4340 Duncan Avenue Suite 222 Saint Louis, MO 63110 United States.
Array Bridge was founded in United States.
In 2024, Array Bridge is currently focus on bio-therapeutic drugs sector.
Above is snippet of Google Trends for "bio-therapeutic drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Array Bridge, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
